App-Quantinova.ai

Novel cmr radiomic correlates with aortic stenosis severity in a single 3-chamber view

Kavitha Vimalesvaran - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

Myocardial extracellular volume pre and post aortic valve replacement in severe aortic stenosis

Noor Sharrack - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

Gadavist

Non-contrast versus contrast transthoracic echocardiography for the detection of left ventricular thrombus, using cardiac magnetic resonance imaging as a reference - a systematic review and meta-analysis

Yu Zhi Phuah - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Fully automated quantitative stress perfusion cardiac mri to assess myocardial perfusion in adult patients with convalescent kawasaki disease and coronary aneurysms: an age and sex-matched analysis

Kevin Cheng - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Kawasaki disease

N/A

Late gadolinium enhancement following covid-19 infection does not predict outcome: a single-centre study

Kavitha Vimalesvaran - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Correlation between serum d-dimer testing and computed tomography pulmonary angiography utilisation and diagnostic outcome: a single centre observational study

Ahmed Kotb - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cataract 6, multiple types

N/A

Validity of cardiovascular polygenic risk scores mostly derived from europeans in multi-ethnic populations

Cristian Topriceanu - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Type 1 diabetes mellitus

N/A

Optimising lipid therapy across north east london through a specialist pharmacist-led multidisciplinary clinical pathway initiative

Nadya Hamedi - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Prevalence and significance of right bundle branch block in young individuals; the experience of a nationwide cardiac screening programme

Hamish MacLachlan - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Progressive cardiac conduction defect

N/A

Using high-sensitivity troponin for mortality prediction after coronary artery bypass graft surgery

Amit Kaura - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Pulmonary arterial hypertension

N/A

The relationship of physical activity, heart rate variability, and night heart rate to established measures of clinical risk in patients with pulmonary arterial hypertension (pah)

Junaid Patel - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

The relationship between diabetes, obesity and cardiovascular disease phenotypes: a uk biobank cohort study

Oliver Brown - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Exploring the relationship between physical activity and covid-19 infection in a young, non-hospitalized cohort in the united kingdom

Raghav Bhatia - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Prediction of incident major adverse cardiac events in patients starting haemodialysis for end stage kidney disease, using clinical laboratory cardiac biomarkers: a real world analysis

Garry McDowell - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

A trial emulation comparing thromboprophylaxis versus no thromboprophylaxis among ward-based patients with covid-19

Amit Kaura - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

dalteparin Subcutaneous

Investigating the effect a titin truncating variant has on atrial fibrillation

Max Cumberland - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Cardiac mesenchymal stromal cell secretome protects human cardiomyocytes from in vitro ischaemia-reperfusion injury

Zuzanna Jablonska - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

N/A

HDACS and vascular smooth muscle cell response to matrix stiffness

Reesha Solanki - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arterial stiffness

Angiotensin II

The PMCA4 calcium transporter and endothelial inflammation

Kinza Khan - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Angiotensin II

Elucidating the ultrastructure of transverse tubules and the sarcoplasmic reticulum in healthy and heart failure sheep atrial cells

Loay Eleyan - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Filters

45280 Abstracts